Instituto Clodomiro Picado, Facultad de Microbiología, Universidad de Costa Rica, San José, Costa Rica.
PLoS Negl Trop Dis. 2024 May 29;18(5):e0012187. doi: 10.1371/journal.pntd.0012187. eCollection 2024 May.
Snakebite envenomation inflicts a high burden of mortality and morbidity in sub-Saharan Africa. Antivenoms are the mainstay in the therapy of envenomation, and there is an urgent need to develop antivenoms of broad neutralizing efficacy for this region. The venoms used as immunogens to manufacture snake antivenoms are normally selected considering their medical importance and availability. Additionally, their ability to induce antibody responses with high neutralizing capability should be considered, an issue that involves the immunization scheme and the animal species being immunized.
METHODOLOGY/PRINCIPAL FINDINGS: Using the lethality neutralization assay in mice, we compared the intrageneric neutralization scope of antisera generated by immunization of horses with monospecific, bispecific/monogeneric, and polyspecific/monogeneric immunogens formulated with venoms of Bitis spp., Echis spp., Dendroaspis spp., spitting Naja spp. or non-spitting Naja spp. It was found that the antisera raised by all the immunogens were able to neutralize the homologous venoms and, with a single exception, the heterologous congeneric venoms (considering spitting and non-spitting Naja separately). In general, the polyspecific antisera of Bitis spp, Echis spp, and Dendroaspis spp gave the best neutralization profile against venoms of these genera. For spitting Naja venoms, there were no significant differences in the neutralizing ability between monospecific, bispecific and polyspecific antisera. A similar result was obtained in the case of non-spitting Naja venoms, except that polyspecific antiserum was more effective against the venoms of N. melanoleuca and N. nivea as compared to the monospecific antiserum.
CONCLUSIONS/SIGNIFICANCE: The use of polyspecific immunogens is the best alternative to produce monogeneric antivenoms with wide neutralizing coverage against venoms of sub-Saharan African snakes of the Bitis, Echis, Naja (non-spitting) and Dendroaspis genera. On the other hand, a monospecific immunogen composed of venom of Naja nigricollis is suitable to produce a monogeneric antivenom with wide neutralizing coverage against venoms of spitting Naja spp. These findings can be used in the design of antivenoms of wide neutralizing scope for sub-Saharan Africa.
在撒哈拉以南非洲,蛇伤造成的死亡率和发病率负担很高。抗蛇毒血清是蛇伤治疗的主要手段,因此迫切需要开发针对该地区具有广泛中和效力的抗蛇毒血清。用于制造蛇抗蛇毒血清的毒液通常是根据其医学重要性和可用性来选择的。此外,还应考虑其诱导具有高中和能力的抗体反应的能力,这是一个涉及免疫方案和被免疫的动物种类的问题。
方法/主要发现:我们使用小鼠致死性中和测定法,比较了用单特异性、双特异性/单属种和多特异性/单属种免疫原免疫马产生的抗血清在属内的中和范围,这些免疫原是用 Bitis spp.、Echis spp.、Dendroaspis spp.、吐毒液的眼镜蛇属或非吐毒液的眼镜蛇属的毒液制成的。结果发现,所有免疫原产生的抗血清都能够中和同源毒液,除了一个例外,还能中和同种异属的毒液(分别考虑吐毒液和非吐毒液的眼镜蛇属)。一般来说,Bitis spp.、Echis spp. 和 Dendroaspis spp. 的多特异性抗血清对这些属的毒液表现出最好的中和谱。对于吐毒液的眼镜蛇属毒液,单特异性、双特异性和多特异性抗血清在中和能力方面没有显著差异。在非吐毒液的眼镜蛇属毒液的情况下也得到了类似的结果,除了多特异性抗血清在中和 Naja melanoleuca 和 N. nivea 的毒液方面比单特异性抗血清更有效。
结论/意义:使用多特异性免疫原是生产针对撒哈拉以南非洲 Bitis、Echis、Naja(非吐毒液)和 Dendroaspis 属蛇毒具有广泛中和覆盖范围的单属种抗蛇毒血清的最佳选择。另一方面,由 Naja nigricollis 毒液组成的单特异性免疫原适合生产针对吐毒液的眼镜蛇属蛇毒具有广泛中和覆盖范围的单属种抗蛇毒血清。这些发现可用于设计针对撒哈拉以南非洲的具有广泛中和范围的抗蛇毒血清。